Researchers: New pain drug tastes awful – perfect!

Pain Therapeutics recruited 45 adults with a history of abusing prescription painkillers and asked them to try their experimental treatment Remoxy and compare it with their experience with OxyContin. Remoxy, the trial participants reported, tasted awful and was much harder to chew--which is exactly what researchers had wanted to hear. Pain Therapeutics is out to develop a more abuse-resistant drug that includes oxycodone, a very effective painkiller which has proven to be very easy to abuse in the past. Story

Suggested Articles

Xcovery's ALK inhibitor shrank tumors in 75% of lung cancer patients, compared to 67% for Pfizer's Xalkori, the first FDA-approved drug of that class.

The FDA accepted the regulatory filing for Biogen's once-failed Alzheimer's drug, aducanumab, with plans to decide its fate by March 7, 2021.

Alexion named a chief diversity officer, while COVID-19 vaccine player has two new members of its C-suite.